Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2012, Article ID 976828, 7 pages
Clinical Study

Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension

1Division of Hypertension and Clinical Pharmacology, Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT 06030, USA
2Medical Data Services Department, Boehringer Ingelheim GmbH, Binger Straße 173, 5216 Ingelheim am Rhein, Germany

Received 29 February 2012; Accepted 21 May 2012

Academic Editor: Thomas Unger

Copyright © 2012 Ravi Marfatia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Amedeo Mugellini, and Valentina Nieswandt, “Candesartan plus hydrochlorothiazide: an overview of its use and efficacy,” Expert Opinion on Pharmacotherapy, vol. 13, no. 18, pp. 2699–2709, 2012. View at Publisher ยท View at Google Scholar
  • L.M. Ruilope, and Helmut Schumacher, “Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertension,” Expert Opinion on Pharmacotherapy, vol. 13, no. 16, pp. 2417–2425, 2012. View at Publisher ยท View at Google Scholar
  • Sverre Kjeldsen, Giuseppe Mancia, Roland Schmieder, Michaela Mattheus, and Thomas Unger, “An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors,” Expert Review of Cardiovascular Therapy, vol. 11, no. 6, pp. 673–682, 2013. View at Publisher ยท View at Google Scholar